USPTO grants patent to Tiziana for fully human monoclonal antibody, TZLS-501 EP News Bureau Aug 24, 2020 The grant of this additional patent on TZLS-501 is of significance for the potential treatment of COVID-19 and other pulmonary…
Tiziana Life Sciences to expedite development of TZLS-501 for COVID-19 EP News Bureau Mar 11, 2020 TZLS-501 is a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients…
